NCT06665490
Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash
Enrolling by Invitation
Not specifiedAges 18–89ObservationalNorthwestern UniversityInvestigator-initiated
~15 participants
Updated 2026-05-01 on ClinicalTrials.gov
What's tested:CLn Body Wash
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change of S. aureus skin microbiome
Measured over 8 weeks
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Study leadership
- Alan Zhou · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults ages 18-89 years of age with active mycosis fungoides.
Patients with concurrent and prior malignancies are allowed as long as any concurrent malignancy does not directly involve the same skin site.
Exclusion
Patients currently or recently (within past 4 weeks) on topical or systemic antibiotics, pregnant persons, or persons with potential of becoming pregnant or are/will be breastfeeding
Patients that have initiated a new skin-directed therapy over the past month.
What this trial measures
- Change of S. aureus skin microbiome8 weeks
Change of S. aureus relative abundance between baseline (Week 0) and Week 8.